These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 13579974)

  • 1. [Experimental and clinical importance of pantothenates of streptomycin, dihydrostreptomycin and viomycin].
    PREZIOSI P
    Riforma Med; 1958 Aug; 72(33):931-3. PubMed ID: 13579974
    [No Abstract]   [Full Text] [Related]  

  • 2. [Streptomycin, dihydrostreptomycin, neomycin & viomycin pantothenates].
    KELLER H
    G Ital Chemioter; 1957; 4(1-2):33-57. PubMed ID: 13562573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of whooping cough with mixture of streptomycin pantothenate and dihydrostreptomycin].
    DAS ALMEIDA JN; DAS ALMEIDA FN
    Presse Med (1893); 1958 Jul; 66(52):1210-1. PubMed ID: 13567566
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative data on the toxicity of different derivatives of dihydrostreptomycin, streptomycin, kanamycin and florimycin].
    Stepanian ES; Gavril'ev SS; Golitsyna LV
    Antibiotiki; 1967 Dec; 12(12):1105-9. PubMed ID: 4175282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental studies in vitro with viomycin panthothenate].
    COLOMBI GC; BASILICO F; TROTTA E
    G Ital Della Tuberc; 1958; 12(4):197-201. PubMed ID: 13574580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical tests of viomycin-pantothenatesulfate (vionactan-P)].
    ARNOLD M
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):203-10. PubMed ID: 13602779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis].
    KUNTZ E
    Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective action of pantothenic acid against toxic effects of streptomycin and dihydrostreptomycin.
    DUCROT R; LEAU O; COSAR C
    Antibiot Chemother (Northfield); 1956 Jun; 6(6):404-10. PubMed ID: 24544020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Viomycin pantothenate in therapy-resistant primary tuberculosis in small children].
    RENOVANZ HD
    Kinderarztl Prax; 1958 Jul; 26(7):289-95. PubMed ID: 13576684
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of calcium pantothenate on the acute and chronic toxicity of streptomycin and dihydrostreptomycin in mice.
    BRIGHAM RS; NIELSEN JK
    Antibiot Chemother (Northfield); 1958 Mar; 8(3):122-9. PubMed ID: 24544677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Technic of intravenous PAS-streptomycin-pantothenate treatment in tuberculosis].
    KUNTZ E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(2):259-64. PubMed ID: 13522541
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical study of various recently discovered antibacillary substances; dihydrostreptomycin and cycloserine panthothenates].
    TACQUET A; VOISIN C; GERNEZRIEUX C
    Therapie; 1956; 11(6):1054-62. PubMed ID: 13409317
    [No Abstract]   [Full Text] [Related]  

  • 13. Auditory nerve toxicity of dihydrostreptomycin sulfate and dihydrostreptomycin pantothenate.
    HEWITT WL; GLORIG A; FINEGOLD S
    Antibiot Annu; 1957-1958; 5():609-13. PubMed ID: 13521866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tolerance of dihydrostreptomycin-pantothenate during a clinical test].
    THIBIER R; VIVIEN JN; LEPEUPLE A; ARNAUD G; ESTELLON P; ASTRIE N
    Rev Tuberc; 1957 Jun; 21(6):666-73. PubMed ID: 13485835
    [No Abstract]   [Full Text] [Related]  

  • 15. The pantothenates of streptomycin, viomycin, and neomycin, new and less toxic salts.
    KELLER H; KRUPE W; MUCKTER H; SOUS H
    Antibiot Annu; 1955-1956; 3():35-8. PubMed ID: 13355243
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative clinical studies on the problem of ototoxic effects of streptomycin-dihydrostreptomycin mixtures with and without addition of pantothenic acid].
    FERLINZ R; HUEMER G
    Tuberkulosearzt; 1960 Jan; 14():9-15. PubMed ID: 13822262
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the detoxication of streptomycin and dihydrostreptomycin].
    GOSSWALD R; KIMMERLE G
    Arzneimittelforschung; 1956 Jul; 6(7):379-84. PubMed ID: 13355699
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gains in the safety & effectiveness obtained from pantothenic streptomycin].
    DUCHESNAY G
    Sem Med Prof Med Soc; 1957 Sep 6-10; 33(32-33):1257-8. PubMed ID: 13486137
    [No Abstract]   [Full Text] [Related]  

  • 19. [METACHROMATIC REACTION FOR THE DEMONSTRATION OF THE AFFINITY OF SOME ANTIBIOTICS TO HEPARIN].
    SZABO I; KELENTEY B; VALYI NAGY T
    Arzneimittelforschung; 1963 Nov; 13():961-3. PubMed ID: 14210432
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicologic studies on the sulfates and pantothenates of streptomycin and dihydrostreptomycin.
    CHILD KJ; DAVIS B; SHARPE HM; TOMICH EG
    Antibiot Annu; 1956-1957; ():574-80. PubMed ID: 13425434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.